Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
September 6–9, 2017 | Mainz/Frankfurt, Germany
The Cancer Research Institute (CRI), the Association for Cancer lmmunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to join forces once again to sponsor the Third International Cancer lmmunotherapy Conference.
The 2017 meeting will take place at the Rheingoldhalle Congress Center in Mainz/Frankfurt, Germany from September 6-9, 2017. The program will focus on "Translating Science into Survival," and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including: neoantigens and vaccines, novel mechanisms of immunosuppression and immune evasion, biomarkers, microbiota, oncolytic viruses, new agents and their mode of action, combination therapies, adoptive cell therapies, new checkpoints, non-checkpoint immunotherapies, and the tumor microenvironment.
This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.
Visit www.cancerimmunotherapyconference.org for more information.